David Campsey, MD
Cardiovascular Disease · Morgantown, WVNPI 1467417048
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $14,487 of the $20,637 with a category attached, or 70.2%. 30 manufacturers reported payments, led by Medtronic at 39.7% of the total. 2025 is the largest year on record at $5,435, 2.6 times the $2,103 reported in 2019. Among cardiovascular disease clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 384 payments — averaging $53.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$3K
- Boston Scientific$2K
- Abiomed$2K
- Edwards Lifesciences$1K
- Bard Peripheral Vascular, Inc.$1K
- plus $3K from 24 others
What the payments were for
- Travel & lodging$6,12130%
- Food & beverage$14,48770%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 165 | $8,196 |
| Abbott | 61 | $3,265 |
| Boston Scientific | 44 | $1,976 |
| Abiomed | 18 | $1,664 |
| Edwards Lifesciences | 12 | $1,443 |
| Bard Peripheral Vascular, Inc. | 9 | $1,188 |
| Inari Medical, Inc. | 3 | $388 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $332 |
| Stryker | 3 | $299 |
| Penumbra, Inc. | 2 | $231 |
| Heartflow, Inc. | 3 | $202 |
| Tactile Systems Technology Inc | 3 | $172 |
| Actelion Pharmaceuticals US, Inc. | 2 | $168 |
| Cerus Corporation | 3 | $160 |
| Endologix LLC | 1 | $146 |
| Impulse Dynamics (USA) Inc. | 1 | $138 |
| Surmodics, Inc. | 2 | $109 |
| Shockwave Medical, Inc | 1 | $97 |
| Johnson & Johnson | 6 | $85 |
| Cardiovascular Systems Inc. | 1 | $80 |
| Angiodynamics, Inc. | 1 | $67 |
| Biotronik Inc. | 3 | $53 |
| Amgen | 2 | $42 |
| Philips North America LLC | 1 | $31 |
| AstraZeneca | 2 | $26 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Cvrx, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,158
- AMPLATZER AMULET$1,076
- Venclose Maven Catheter$1,029
- Resolute$999
- Watchman$966
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$740
- RESOLUTE ONYX$608
- SYMPLICITY G3$396
- ONYX FRONTIER$354
- FLOWTRIEVER CATHETER, S$297
- CT THROMBECTOMY SYSTEM KIT$297
- CLOTTRIEVER BOLD CATHETER$172
- FFRct$152
- Torus Stent Graft System$146
- ENDOCROSS Device$146
- Integrity$142
- OPTIMIZER$138
- COREVALVE EVOLUT R$137
- Indigo System$133
- GENERAL - THERAPIES$124
How this compares
$20,637 in reported general payments places this provider in the 90th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 152 | $156,802 |
| EntrestoSacubitril/Valsartan | 26 | $30,696 |
| XareltoRivaroxaban | 26 | $27,699 |
| Repatha SureclickEvolocumab | 13 | $16,521 |
| BrilintaTicagrelor | 13 | $14,491 |
| Metoprolol Succinate | 320 | $4,960 |
| Dofetilide | 12 | $4,120 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 67 | $2,381 |
| Rosuvastatin Calcium | 144 | $2,144 |
| Atorvastatin Calcium | 198 | $2,025 |
| Ranolazine ErRanolazine | 11 | $1,444 |
| Ezetimibe | 36 | $1,356 |
| Losartan Potassium | 127 | $1,267 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 84 | $1,156 |
| Lisinopril | 122 | $915 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $156,802152 claims |
| Johnson & JohnsonXarelto | $85 | $27,69926 claims |
| AstraZenecaBrilinta | $26 | $14,49113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 100 cardiovascular disease providers in West Virginia.
Other cardiovascular disease in Morgantown
- Partho SenguptaMorgantown$131K
- Madhavi KadiyalaMorgantown$29K
- Morgan LyonsMorgantown$7K
- Muchi Ditah ChobufoMorgantown$7K
- Raahat BansalMorgantown$6K
- Walid GharibMorgantown$6K
- David TinglerMorgantown$6K
- Yasmin HamiraniMorgantown$5K
- Ruby HavistinMorgantown$4K
- Mohamed Al HajjiMorgantown$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.